DEVELOPMENT OF SYSTEMIC ANTISENSE TREATMENT IN DYSTROPHIC MOUSE MODELS FOR DUCHENNE MUSCULAR DYSTROPHY

被引：0

作者：

Aartsma-Rus, Annemieke ^{[1
]}

de Winter, Christa ^{[1
]}

van Putten, Maaike ^{[1
]}

Karnaoek, Tatyana ^{[2
]}

van Deutekom, Judith ^{[2
]}

van Ommen, Gert-Jan ^{[1
]}

机构：

[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands

[2] Prosensa BV, Leiden, Netherlands

来源：

NUCLEIC ACID THERAPEUTICS | 2011年 / 21卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：A2 / A2

页数：1

共 50 条

[21] Muscle physiology properties of mouse models for Duchenne muscular dystrophy [J].

van Putten, M. ;

Terry, R. ;

Hulsker, M. ;

Wells, K. E. ;

Aartsma-Rus, A. ;

Wells, D. J. .

NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) :840-840

[22] Jagged1 Ameliorates Dystrophic Phenotypes in Mouse Model of Duchenne Muscular Dystrophy [J].

Zhang, Yuanfan Tracy ;

Lambert, Matthias R. ;

Widrick, Jeffrey J. ;

Conner, James R. ;

Spinazzola, Janelle M. ;

de Souza Leite, Felipe ;

Kunkel, Louis M. .

MOLECULAR THERAPY, 2022, 30 (04) :501-502

[23] Local and Systemic Gene Editing in a Mouse Model of Duchenne Muscular Dystrophy [J].

Nelson, Christopher ;

Gemberling, Matthew ;

Hakim, Chady H. ;

Ousterout, David G. ;

Thakore, Pratiksha I. ;

Castellanos, Ruth M. ;

Madhavan, Sarina ;

Pan, Xiufang ;

Ran, F. Ann ;

Yan, Winston ;

Asokan, Aravind ;

Zhang, Feng ;

Duan, Dongsheng ;

Gersbach, Charles A. .

MOLECULAR THERAPY, 2016, 24 :S191-S191

[24] A historical perspective on the development of antisense oligonucleotide treatments for Duchenne muscular dystrophy and spinal muscular atrophy [J].

Aartsma-Rus, Annemieke ;

Takeda, Shin'ichi .

JOURNAL OF NEUROMUSCULAR DISEASES, 2025,

[25] Dollars and antisense for Duchenne muscular dystrophy Eteplirsen and dystrophin [J].

Zingariello, Carla D. ;

Kang, Peter B. .

NEUROLOGY, 2018, 90 (24) :1091-1092

[26] Antisense therapy corrects Duchenne muscular dystrophy mutation [J].

Butcher, J .

LANCET NEUROLOGY, 2003, 2 (08) :458-458

[27] Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy [J].

Wilton-Clark, Harry ;

Yokota, Toshifumi .

PHARMACEUTICS, 2023, 15 (03)

[28] PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy [J].

Hammond, Suzan M. ;

Wood, Matthew J. A. .

CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (04) :478-486

[29] The antisense oligonucleotide BMN 351 durably ameliorates dystrophic phenotypes in a mouse model of exon 51-skip-amenable Duchenne muscular dystrophy [J].

Porco, D. ;

Neil, D. ;

Crawford, B. ;

O'Neill, C. ;

Qi, Y. ;

Oppeneer, T. ;

Larimore, K. ;

Gupta, S. ;

Beretta, F. .

NEUROMUSCULAR DISORDERS, 2023, 33 :S104-S104

[30] Animal Models of Duchenne Muscular Dystrophy, with Special Reference to the mdx Mouse [J].

Blain, Alison ;

Greally, Elizabeth ;

Laval, Steve ;

Blamire, Andrew ;

MacGowan, Guy ;

Straub, Volker .

BIOCYBERNETICS AND BIOMEDICAL ENGINEERING, 2012, 32 (04) :3-15

← 1 2 3 4 5 →